SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007545
Filing Date
2022-05-06
Accepted
2022-05-06 11:46:23
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20220331x10q.htm   iXBRL 10-Q 1031267
2 EX-10.1 imgn-20220331xex10d1.htm EX-10.1 647742
3 EX-31.1 imgn-20220331xex31d1.htm EX-31.1 10916
4 EX-31.2 imgn-20220331xex31d2.htm EX-31.2 10952
5 EX-32 imgn-20220331xex32.htm EX-32 10001
6 GRAPHIC imgn-20220331xex10d1002.jpg GRAPHIC 7018
  Complete submission text file 0001558370-22-007545.txt   6150757

Data Files

Seq Description Document Type Size
7 EX-101.SCH imgn-20220331.xsd EX-101.SCH 48663
8 EX-101.CAL imgn-20220331_cal.xml EX-101.CAL 33695
9 EX-101.DEF imgn-20220331_def.xml EX-101.DEF 246068
10 EX-101.LAB imgn-20220331_lab.xml EX-101.LAB 427342
11 EX-101.PRE imgn-20220331_pre.xml EX-101.PRE 351885
56 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20220331x10q_htm.xml XML 769587
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 22899685
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences